MB "Inovacinis rytojus" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
91,644 |
- |
4,061 |
3,844 |
- |
4.53 |
4.19 |
2,429 |
8,775 |
13,204 |
6,785 |
2023 |
---|
178,504 |
99,723 |
56,049 |
53,206 |
29,724 |
98.58 |
29.81 |
42,951 |
10,739 |
9,029 |
51,657 |
2024 |
---|
33,129 |
33,129 |
-1,076 |
-1,160 |
-1,160 |
100.00 |
-3.50 |
21,959 |
21,714 |
938 |
42,735 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
33,129 €-81 % *
Sales per employee (€)
33,129 €-67 % *
Profit before tax (€)
-1,076 €-102 % *
Net Profit (€)
-1,160 €-102 % *
Profit per employee (€)
-1,160 €-104 % *
Total profitability (%)
100.00 %1.44 % *
Net profitability (%)
-3.50 %-111.74 % *
Equity (€)
21,959 €-49 % *
Amounts Payable And Liabilities (€)
21,714 €102 % *
Non-current Assets (€)
938 €-90 % *
CurrentAssets (€)
42,735 €-17 % *